Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Depomed Inc (NASDAQ:DEPO)

10.97
Delayed Data
As of Jun 26
 -0.07 / -0.63%
Today’s Change
9.38
Today|||52-Week Range
27.02
-39.12%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 2
2016
Quarter 3
2016
Quarter 4
2016
Quarter 1
2017
Revenue and IncomeNet Revenues116.7M110.5M123.9M90.4M
 
 
 
 
 
Cost of Goods Sold20.3M19.6M22.0M17.2M
 
 
 
 
 
Depreciation And Amortization27.7M27.7M26.4M26.3M
 
 
 
 
 
 
Operating ExpensesGross Income68.7M63.2M75.5M46.9M
 
 
 
 
 
General Expenses59.1M61.9M57.6M58.6M
 
 
 
 
 
Research And Development7.1M10.4M9.2M5.1M
 
 
 
 
 
Total Operating Expenses107.1M109.2M106.0M102.1M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income9.6M1.3M17.9M-11.7M
 
 
 
 
 
Extraordinary Credit110.0K0.000.005.0M
 
 
 
Extraordinary Charge-6.4M-686.0K0.00-531.0K
 
 
 
 
Interest Expense On Debt19.5M19.7M20.5M19.6M
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-16.2M-18.9M-2.5M-26.5M
 
 
 
 
 
Income Taxes-5.7M-6.0M-41.9M-202.0K
 
 
 
 
 
Net Income-10.5M-12.9M-44.4M-26.7M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS61.2M61.4M61.7M62.1M
 
 
 
 
 
Shares To Calculate EPS Diluted61.2M61.4M61.7M62.1M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.17-$0.21-$0.72-$0.43
 
 
 
 
 
EPS Diluted-$0.17-$0.21-$0.72-$0.43